About Xanomeline API
Therapeutic Category 中枢神経系 (CNS)
CAS Number
131986-45-3
API Technology
Synthetic
Dose Form
Oral Solid/Capsules
Dr Reddy's Development Status
Under Development
Mechanism of Action
Xanomeline is a muscarinic acetylcholine receptor agonist that primarily targets the M1 and M4 receptor subtypes. It modulates neurotransmitter circuits, including acetylcholine, dopamine, and glutamate, which can provide therapeutic benefits in schizophrenia
Indication
Xanomeline is indicated for the treatment of schizophrenia
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
